A comprehensive new review published in Case Studies in Chemical and Environmental Engineering argues that the answer to this problem may lie in an element long overshadowed by its more famous rival. Advanced oxidation processes, which generate highly reactive chemical species capable of shredding organic molecules apart, have traditionally relied on iron, following the classic Fenton chemistry discovered in the late nineteenth century. But iron-based systems carry a punishing constraint: they work well only in acidic conditions, around pH 2.5 to 4, requiring costly acidification and neutralization steps and producing iron-laden sludge that must be disposed of. Copper, the review’s authors contend, offers a fundamentally more flexible alternative.

The chemistry behind this advantage is striking. Iron(III), the oxidized form that must be recycled back to iron(II) to keep the catalytic cycle turning, precipitates out of solution above pH 4 because of an extraordinarily low solubility product, roughly 4 × 10⁻³⁸. Copper(II), by contrast, remains soluble at neutral pH, with a solubility product about eighteen orders of magnitude higher. More importantly, the rate-limiting reduction step is dramatically faster for copper: copper(II) reacts with hydrogen peroxide at a rate constant of 4.6 × 10² M⁻¹s⁻¹, while the equivalent iron reaction crawls along at 9.1 × 10⁻⁷ M⁻¹s⁻¹. The result is a catalyst that maintains removal efficiencies above 80 percent across the entire pH range, where iron systems collapse once conditions turn neutral or alkaline.

Copper’s multivalent nature adds another dimension. Unlike iron, which cycles mainly between two oxidation states, copper can shuttle among three: Cu(I), Cu(II), and Cu(III). The Cu(I) reaction with hydrogen peroxide runs roughly four orders of magnitude faster than the iron equivalent, and Cu(III) itself is a formidable oxidant, with a redox potential of 1.7 to 2.4 volts, far exceeding the iron(III)/iron(II) couple. This triple-state flexibility allows copper catalysts to activate a whole family of oxidants, including peroxymonosulfate, peroxydisulfate, hydrogen peroxide, and peracetic acid, through both radical pathways involving hydroxyl and sulfate radicals and non-radical pathways dominated by singlet oxygen or direct electron transfer. Iron systems, by comparison, are overwhelmingly radical-driven.

That dual pathway capability is both a strength and a scientific puzzle. In some copper systems, radical scavengers quench nearly all degradation; in others, radicals contribute almost nothing. The dominant mechanism can shift with pH, moving from radical-dominated oxidation under acidic conditions to Cu(III)-mediated non-radical oxidation at neutral and alkaline values. Part of the confusion stems from detection limits: conventional electron paramagnetic resonance cannot distinguish Cu(III) from hydroxyl or sulfate radicals because their spin-trap signals overlap. The review highlights emerging diagnostic tools, including Raman spectroscopy of the Cu(III)-OH stretching band at 614 cm⁻¹, selective copper chelators, and ultraviolet-visible detection of Cu(III)-periodate complexes, and urges researchers to combine multiple lines of evidence rather than relying on any single method.

Catalyst design is advancing rapidly along several fronts. Simple copper salts are abundant and cheap, with municipal wastewater containing 5 to 10 milligrams per liter of soluble copper, but Cu(II) alone is sluggish at activating oxidants. Adding reductants or ligands helps: gallic acid boosted tetrabromobisphenol A removal from 40 to 80 percent in a Cu(II)/peroxymonosulfate system, while thiosulfate accelerated benzoic acid degradation nearly sixfold. Heterogeneous catalysts perform far better still. Copper oxide activated peroxymonosulfate achieved complete bisphenol A removal where soluble copper managed only 15 percent, and lower-valence Cu₂O outperformed CuO dramatically on similar targets. Bimetallic combinations amplify the effect further; adding iron(III) to zero-valent copper more than doubled acetaminophen degradation beyond the sum of the individual metals, a synergy attributed to denser active sites and faster interfacial electron transfer.

The most transformative platform, however, may be copper integrated with conductive carbon frameworks, particularly single-atom catalysts derived from metal-organic frameworks. When individual copper atoms are anchored within nitrogen-doped carbon matrices, they gain both electronic stabilization and exceptional catalytic versatility. Carbon-coated copper oxide achieved complete tetracycline removal in 40 minutes, double the performance of bare CuO, while a CuBTC metal-organic framework annealed at 300 degrees Celsius degraded bisphenol A completely within 30 minutes with copper leaching below 0.02 percent. Even the coordination geometry matters: Cu-N₄ sites tend to promote radical pathways, whereas unsaturated Cu-N₂ sites drove complete removal of 2,4-dichlorophenol sustained over 14 days. Computational studies using density functional theory now allow researchers to predict how heteroatom doping tunes copper’s electronic structure and oxidant adsorption, guiding rational design rather than trial and error.

Real-world performance, though, depends on messy details. Oxidant choice matters, with an empirical activity ranking of peroxymonosulfate and peracetic acid above peroxydisulfate and hydrogen peroxide, though the authors caution this trend is not universal. Combining oxidants can be surprisingly powerful: adding hydrogen peroxide to a Cu(II)/peroxymonosulfate system raised naproxen degradation rates 28-fold, because hydrogen peroxide’s lower redox potential thermodynamically favors the copper redox cycle. Dosage follows a Goldilocks pattern, since excessive oxidant triggers radical self-quenching and excess catalyst increases copper leaching. Water matrix constituents complicate matters further. Anions often scavenge radicals into less reactive secondary species, yet chloride can sometimes enhance degradation by forming copper-chloride complexes. Dissolved organic matter can inhibit oxidation by competing for reactive species, but at low concentrations it may actually stabilize copper redox cycling and act as an electron shuttle.

Safety remains the field’s central tension. Copper is a more potent inducer of oxidative stress in microorganisms than iron, and World Health Organization guidelines cap copper in surface water at 2 milligrams per liter, well below the 5 milligram-per-liter limit for iron. The review notes that most reported copper leaching falls below regulatory thresholds, with some catalysts releasing as little as 0.003 milligrams per liter over repeated cycles, but it insists compliance alone is insufficient evidence of safety. Chronic low-level release, cumulative accumulation, and shifts in copper speciation during long-term operation all demand scrutiny. Minimizing leaching, the authors argue, should be treated as a primary design criterion rather than an afterthought.

The path from laboratory to treatment plant is still long. Most copper-based systems have been tested only in short-term batch experiments with suspended powder catalysts, and the technology’s readiness level remains low to medium compared with fully proven iron Fenton processes. The review calls for integrated catalyst-reactor designs, including packed-bed, flow-through, and catalytic-membrane configurations that enable catalyst recovery and continuous operation, alongside techno-economic and life-cycle assessments to confirm genuine environmental benefit. It also urges researchers to look beyond parent-compound removal toward full mineralization, transformation-product identification, and toxicity testing, since partially oxidized byproducts can sometimes be as harmful as the original pollutants. If those challenges can be met, copper’s pH resilience, oxidant versatility, and rapidly maturing single-atom catalyst designs could position it as the backbone of next-generation water purification, turning an abundant, versatile metal into a decisive weapon against the micropollutants threatening global water security.

Subject of Research: Copper-based advanced oxidation processes for degrading organic micropollutants in water treatment

Article Title: Copper-based advanced oxidation processes for micropollutant degradation: A review of reaction mechanisms, modulation strategies, and future applications

Article References: Ly, Q. V., Nguyen, D. V., Quang, D. V., Kim, T.-H., Hwang, Y., Nguyen, T., Wu, D., & Hur, J. (2026). Copper-based advanced oxidation processes for micropollutant degradation: A review of reaction mechanisms, modulation strategies, and future applications. Case Studies in Chemical and Environmental Engineering, 14, Article 101495. https://doi.org/10.1016/j.cscee.2026.101495

Image Credits: AI Generated

DOI: 10.1016/j.cscee.2026.101495

Keywords: copper catalysts, advanced oxidation processes, micropollutants, water treatment, Fenton reaction, single-atom catalysts, sulfate radicals, Cu(III) oxidation, metal-organic frameworks, pharmaceuticals in water, antimicrobial resistance, wastewater reuse

The scaffold’s design reflects a growing recognition in biomaterials science that tumor removal and tissue reconstruction have traditionally been treated as separate clinical challenges. Surgeons excise the tumor, then wait—sometimes through multiple additional interventions—for the bone defect to heal, all while monitoring for local recurrence. The new scaffold attempts to collapse this timeline by embedding three complementary therapeutic functions into a single printed structure. Each component was chosen for a specific biochemical role, and together they form what the researchers describe as a catalytic-immune system working in concert with osteoinductive signaling.

At the heart of the antitumor function is a dopamine–manganese coordination nanozyme, abbreviated DM, which forms a mussel-inspired catalytic coating on the scaffold surface. The mussel-inspired chemistry is significant because polydopamine coatings adhere robustly to diverse substrates under mild aqueous conditions, allowing the nanozyme to be integrated without harsh coupling reagents that could damage the delicate biological cargo carried elsewhere in the scaffold. Nanozymes—engineered nanomaterials that mimic the catalytic activity of natural enzymes—have attracted intense interest because they combine enzyme-like reactivity with the stability, tunability, and manufacturability of synthetic materials.

The DM nanozyme behaves differently depending on the chemical environment it encounters, which is the key to its dual function. In the acidic milieu characteristic of tumor tissue, it exhibits peroxidase-like activity, catalyzing Fenton-type reactions that generate highly reactive hydroxyl radicals. These radicals attack tumor cells directly, while the nanozyme simultaneously depletes glutathione, the antioxidant molecule that cancer cells rely on to neutralize oxidative stress. The combined effect overwhelms the tumor cells’ redox defenses and induces oxidative stress–mediated cell death. This chemodynamic strategy exploits a vulnerability that is specific to the tumor microenvironment, so the lethal chemistry is triggered where the acidity marks malignant tissue rather than throughout the body.

Under physiological pH, however, the same nanozyme switches roles entirely. In the neutral conditions of healthy regenerating tissue, DM displays superoxide dismutase-like and catalase-like activities, the two enzymatic steps that together convert destructive superoxide radicals into water and oxygen. In this mode, the nanozyme scavenges reactive oxygen species and helps maintain redox homeostasis. That matters for bone repair because excessive reactive oxygen species are known to impair osteoblast function and drive the chronic inflammation that stalls fracture healing. By quenching oxidative stress at the defect site, the coating creates a biochemical environment in which bone-forming cells can operate, effectively turning the tumor-killing catalyst into a tissue-protective antioxidant once the malignant chemistry has been neutralized.

The second therapeutic arm of the scaffold is immunological. Encapsulated within the hydrogel are dendritic cell-derived exosomes loaded with a cyclic dinucleotide that acts as an agonist of STING, the stimulator of interferon genes pathway. STING signaling is a central hub of innate immunity: when activated, it prompts cells to produce type I interferons and other inflammatory mediators that recruit and activate cytotoxic T lymphocytes capable of hunting down tumor cells. Dendritic cells are the professional antigen-presenting cells of the immune system, and exosomes derived from them offer a natural delivery vehicle that can ferry their immunostimulatory cargo to target cells while evading rapid clearance. The scaffold’s hydrogel matrix provides sustained release of these Dex-CDN particles, prolonging the local immune activation window rather than delivering a single transient dose.

This local immune strategy addresses one of the most persistent fears after bone-metastatic tumor surgery: microscopic disease left behind at the resection margin. Catalytic therapy kills cells it can reach directly, but the STING agonist is intended to do something different—convert the surgical site itself into an immunological alert zone where the patient’s own adaptive immune system is primed against residual tumor cells. Combining chemodynamic cell killing with immune checkpoint-free immune activation is an increasingly popular concept in oncology research, because dying tumor cells release antigens that, in the presence of interferon signaling, can be presented to T cells to generate a systemic antitumor response.

The third arm of the scaffold is dedicated to rebuilding bone. The researchers crosslinked the hydrogel network with methacrylated osteogenic growth peptide, or OGP-MA. Osteogenic growth peptide is a naturally occurring short peptide found in bone and blood that stimulates osteoblast proliferation and bone formation. By modifying it with methacrylate groups, the team made it copolymerizable into the GelMA network, so the osteogenic signal is not simply adsorbed onto the surface where it would diffuse away quickly, but is covalently incorporated into the scaffold architecture. According to the study, OGP-MA triggers osteogenic differentiation through the BMP/Smad signaling pathway, one of the canonical cascades that drives mesenchymal stem cells toward the bone-forming lineage.

The choice of a 3D-printed sodium alginate/GelMA hydrogel as the carrier is itself a technical decision with clinical implications. Alginate contributes mechanical robustness and printability, while GelMA—a gelatin derivative bearing methacrylate groups that crosslink under light—offers cell-adhesive motifs and controllable degradation. Printing the scaffold allows its internal architecture and pore structure to be tailored to the geometry of the specific bone defect, an advantage over prefabricated implants when reconstructing irregular post-resection cavities. The hydrogel’s hydrated, soft matrix is also compatible with the encapsulated exosomes and peptide, protecting the biological cargo while allowing gradual release as the material degrades.

The integrated design—catalytic tumor ablation, STING-driven immunity, and OGP-driven osteogenesis within one printed implant—offers what the authors present as a promising strategy for localized tumor control and bone regeneration following resection of bone-metastatic tumors. The work was supported by funding from China’s National Key Research and Development Program, the National Science and Technology Major Project, the National Natural Science Foundation of China, and several regional research programs, and the animal experiments were approved by the Dongguan People’s Hospital Laboratory Animal Welfare and Ethics Committee. While the platform will require extensive further validation before clinical use, it illustrates a broader shift in biomaterials engineering: implants conceived not as inert scaffolds that merely occupy space, but as programmable microenvironments that sense where they are, choose their chemistry accordingly, and orchestrate the body’s own defenses and repair mechanisms in the critical weeks after surgery.

Subject of Research: A 3D-printed hydrogel scaffold combining catalytic antitumor therapy, STING-mediated immunity, and osteogenic peptide signaling for bone repair after tumor resection

Article Title: A catalytic-immune OGP peptide-crosslinked 3D-printed hydrogel scaffold for concurrent antitumor therapy and bone regeneration

Article References: He, J., Wu, J., Wang, L., Yin, S., Yu, K., Liu, Y., Xu, D., Ji, T., Gao, Y., Du, Y., Gao, X., Cai, L., Xie, C., & Lu, X. (2026). A catalytic-immune OGP peptide-crosslinked 3D-printed hydrogel scaffold for concurrent antitumor therapy and bone regeneration. Advanced Composites and Hybrid Materials. https://doi.org/10.1007/s42114-026-02048-3

Image Credits: AI Generated

DOI: 10.1007/s42114-026-02048-3

Keywords: 3D-printed hydrogel scaffold, bone metastasis, nanozymes, Fenton reaction, STING agonist, dendritic cell exosomes, osteogenic growth peptide, bone regeneration, chemodynamic therapy, GelMA, tumor microenvironment, BMP/Smad signaling